Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001655247 | SCV001867651 | benign | not provided | 2018-06-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807483 | SCV002054568 | benign | Myoclonus, familial, 2 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807480 | SCV002054569 | benign | Cognitive impairment with or without cerebellar ataxia | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807481 | SCV002054570 | benign | Developmental and epileptic encephalopathy, 13 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807482 | SCV002054571 | benign | Seizures, benign familial infantile, 5 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV004594457 | SCV005087592 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 99% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 92. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001655247 | SCV005228874 | benign | not provided | criteria provided, single submitter | not provided |